Skip to main content

What the FDA labels say about taking them together

Elagolix and norethindrone

Elagolix's FDA label of December 19, 2025 names norethindrone in its warnings and precautions section; the norethindrone labels PlainMeds reads (2) do not name elagolix. The elagolix label: “Co-administration of ORILISSA with COCs containing norethindrone acetate did not show reduction in plasma concentrations of norethindrone.”

Check it at the source: the elagolix FDA label on DailyMed (effective December 19, 2025, AbbVie Inc.); the norethindrone FDA label on DailyMed (effective January 31, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the elagolix label say about norethindrone?

Elagolix label, warnings and precautions

Co-administration of ORILISSA with COCs containing norethindrone acetate did not show reduction in plasma concentrations of norethindrone [see Drug Interactions ( 7.1 ), Clinical Pharmacology ( 12.3 )].

Source: FDA drug label (Orilissa), AbbVie Inc., effective December 19, 2025 (SPL set a86757b3-09c5-fd3b-1223-244e94f50a66), via openFDA; the full label on DailyMed

What does the norethindrone label say about elagolix?

Norethindrone's label (effective January 31, 2026) and its 1 other brand-application label do not name elagolix in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norethindrone), Glenmark Pharmaceuticals Inc., USA, effective January 31, 2026 (SPL set 0d2f8fea-3675-40d2-afd9-9fcb148dbd4b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Elagolix generic labelers
18Norethindrone generic labelers
ElagolixNorethindrone
Labeled forn/aBirth control
Boxed warningNoNo
Pharmacy cost (NADAC)$43.81 per tablet 150 mg tablet$0.290 per tablet 5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?